Akba Conversation (2024)

1. Akebia Therapeutics, Inc. (AKBA) Stock Forum & Discussion

Find the latest Akebia Therapeutics, Inc. (AKBA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and ...
Find the latest Akebia Therapeutics, Inc. (AKBA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

14 aug 2021 · The FDA assigned the application a standard review and a PDUFA target action date of March 29, 2022. Cash, cash equivalents and available-for- ...
$AKBAMarket Price - $2.56Average Hold - $3.40Accumulate - Sub $2.45 (raised from $2.30)Price Target - $5Estimated Time Hold - 2QSupport - $2.75, $3.40Floor - $2.09Double Down Target - Sub $2Option - N/AMicro DD - In March, Akebia submitted an NDA to the FDA for vadadustat for the treatment of anemia due to CKD in both adult patients on dialysis and adult patients not on dialysis. In late May, the FDA accepted for filing the NDA for vadadustat for the treatment of anemia due to CKD in both adult patients on dialysis and adult patients not on dialysis. The FDA assigned the application a standard review and a PDUFA target action date of March 29, 2022. Cash, cash equivalents and available-for-sale securities as of June 30, 2021 were $247.0 million .

Get stock insights, analysis and discussion about Akebia Therapeutics Inc (NDAQ:AKBA). Join the AKBA discussion on Canada's largest online investor ...
Get insights, analysis and discussion about Akebia Therapeutics Inc (NDAQ:AKBA) from Canada’s largest online community of active investors.
See Also
Decision analysis - What, Why, and How How to save Kaitlyn in The Quarry Craigs List Worc Kaitlyn Krems- Wiki, Bio, Age, Height, Boyfriend, Net Worth

AKBA (3-O-acetyl-11-keto-beta-boswellic acid) is één van de belangrijkste stoffen in een Boswellia extract. AKBA heeft recentelijk veel goede wetenschappelijke ...
Bestel hier de beste Boswellia Serrata supplementen. Alles op voo

2 dagen geleden · Get stock insights, analysis and discussion about Akebia Therapeutics Inc (NDAQ:AKBA). Join the AKBA discussion on Canada's largest online ...
1. Akebia Therapeutics, Inc. (AKBA)AKBAFind the latest Akebia Therapeutics, Inc. (AKBA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. See details › 2. Akebia Therapeutics, Inc. (AX9.F) Stock Forum & DiscussionFind the latest Ak...

17 apr 2015 · Find the latest Akebia Therapeutics Inc (AKBA) discussion and analysis from iHub's community of investors.
See Also
What Time Does Citibank Direct Deposit Hit
Find the latest Akebia Therapeutics Inc (AKBA) discussion and analysis from iHub's community of investors.

6 dagen geleden · There is no specific information indicating that Akebia Therapeutics (AKBA) will present good news today ... Continue this conversation link.
There is no specific information indicating that Akebia Therapeutics (AKBA) will present good news today. However, it's important to note that the company recently announced the approval of Vafseo® (vadadustat) in Australia, which could be seen as positive news. Additionally, the company's CEO, John Butler, is scheduled to present at the H.C. Wainwright 25th Annual Global Investment Conference on September 11, 2023, which could provide an opportunity for the company to share updates or positive developments.Therefore, while there is no guarantee that the company will present good news today, these recent announcements and upcoming presentation could potentially have positive implications for the company.

Bevat niet: conversation | Resultaten tonen met:conversation
View live Akebia Therapeutics, Inc. chart to track its stock's price action. Find market predictions, AKBA financials and market news.

Akebia Therapeutics Inc AKBA:NASDAQ · Open0.9434 · Day High0.96 · Day Low0.9025 · Prev Close0.94 · 52 Week High2.48 · 52 Week High Date03/28/24 · 52 Week Low0.78 · 52 ...
Get Akebia Therapeutics Inc (AKBA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

The biotech company Akebia Therapeutics Inc. trades as AKBA stock on the Nasdaq All ... Log in or sign up to join the conversation. LoginSign up. 0 Comments on ...
The biotech company Akebia Therapeutics Inc. trades as AKBA stock on the Nasdaq All Markets. Akebia Therapeutics Inc (Akebia Therapeutics) is a biopharmaceutical company focused on the development and commercialization of novel therapeutics based on hypoxia-inducible factors for patients with kidney disease and other metabolic disorders. Its lead product candidate vadadustat is a HIF-PH inhibitor, a regulator for the production of red blood cells, or RBCs, in the body, as well as other important metabolic functions for the treatment of anemia due to chronic kidney disease (CKD).